Clinical trials in human gene therapy. An overview;THERAPIE GENIQUE: LE POINT SUR LES ESSAIS CLINIQUES

Medecine/Sciences

Volumn 12, Issue 1, 1996, Pages 73-83

  Valère, Thomas ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANADA; CANCER; CHINA; CLINICAL PROTOCOL; CLINICAL TRIAL; EUROPE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; JAPAN; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SAFETY; TRANSGENE; UNITED STATES;

ADA;

EID: 0030026424     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Clinical protocols (submitted to agencies that regulate gene transfer clinical studies). Cancer Gene Ther 1995 ; 2 : 225-34.
2. Tables d'information sur la transgénèse humaine en cours en France et à l'étranger. Accessible sur Internet. Serveur Web de l'Institut Pasteur, page «Thérapie génique», adresse http://www.pasteur.fr/ ou contacter @pasteur.fr.
3. TMC Development. The RAC report. Some notes and selected documentation on the meeting of June 8th and 9th, 1995.
4. Stewart AK, Dube ID, Kamel-Reid S, Keating A (Toronto Hospital TTH). A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. Hum Gene Ther 1995 ; 6 : 107-19.
5. Cohen-Hagenauer O. Currently ongoing or planned (close to initiation) clinical trials in Europe. EWGT Newsletter 1995 , 2.
6. Caplen NJ, Alton EWFW, Middelton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, Huang L, Porteous DJ, Williamson R, Geddes DM (St Mary's Hospital, London). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature. Med 1995 ; 1 : 39-46.
7. Hoogerbrugge PM, Beusechem V, Valerio D , Moseley A, Harvey M, Fischer A, Debree M, Gaspar B, Moigan G, Levinsky R (Med Biol Lab, TNO, The Netherlands ; CHU Necker, Paris ; Inst Child Health. London). Gene therapy in 3 children with adenosine deaminase deficiency. Blood 1993 ; 82 (suppl 1) : 315a ; Abstract 1246. (l'article complet est actuellement soumis.)
8. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzoari E, Maggini D, Rossi C, Servida P, Ugazio AG, Mavilio F. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995 ; 270 : 470-5.
9. Mackiewiz A, Gorny A, Laciak M, Maicki J, Murawa P, Nowak J (GreatPoland Cancer Center, Poznan). Gene therapy of human melanoma. Immunisation of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting IL-6 and soluble IL-6 receptor. Hum Gene Ther 1995 ; 6 : 805-11.
10. Lu DR, Zhou JM, Zheng B, Qiu XF, Xue JL, Wang JM, Meng PL, Han FL, Ming BH, Wang XP (Fudan University, Shanghai). Stage I clinical trial of gene therapy for hemophilia B. Sci China B (China) 1993 ; 36: 1342-51.
11. Swinbanks D. Japan turns to US for help in launching gene therapy (news). Nature 1994 ; 371 : 6.
12. Rosenberg SA, Aebersold P, Cornetta C, Kasid A, Morgan R, Moen R, Karson E, Lotze M, Yang J, Topalian S, Merino M, Culver K, Miller D, Blaese R, Anderson F. Gene transfer into humans - immunotherapy of patients with advanced melanoma, using TIL modified by retroviral gene transduction. N Engl J Med 1990 ; 323: 570-8.
13. Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with TIL. Science 1986 ; 233 : 1318-21.
14. Anderson W, Blaese R, Culver K. The ADA human gene therapy protocol. Hum Gene Ther 1990 ; 1 : 331-62.
15. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995 ; 1 : 890-3.
16. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity. Proc Natl Acad Sci USA 1993 ; 90:11307-11.
17. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA. Preclinical efficacy of a prototype DNA vaccine : enhanced protection against antigenic drift in influenza virus Nature Med 1995 ; 1 : 583-7.
18. Wolff TA, Malone RW, Williams P, Chong W, Ascadi G, Jani A, Felgner P. Direct gene transfer into mouse muscle in vivo. Science 1990 ; 247 : 1465-8.
19. Crystal R, McElvaney M, Rosenfeld M, Chu C, Mastrangeli A, Hay J, Brody S, Jaffe H, Eissa N, Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 1994 ; 8 : 42-50.
20. Aebersold P, Kasid A, Rosenberg SA. Selection of gene-marked TIL from post-treatment biopsies: a case study. Hum Gene Ther 1990 ; 1 : 373-84.
21. Brenner M, Rill D, Holladay M, Heslop H, Moen R, Buschle R, Krance R, Santana V, Andeson WF, Ihle J. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993 ; 342 : 1134-7
22. Rill D, Santana V, Roberts W, Nilson T, Bowman L, Krance R, Heslop H, Moen R, Ihle J, Brenner M. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994 ; 84 : 380-3
23. Rubin J, Charboneau JW, Reading C, Kovach JS. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer. Hum Gene Ther 1994 ; 5 : 1385-99.
24. Moolten F. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes : paradigm for a prospective cancer control strategy. Cancer Res 1986 ; 46 : 5276-9.
25. Oldfield EH, Ram Z, Chiang Y, Blaese RM. Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I/II study. Hum Gene Ther 1995 ; 6 : 55-85.
26. Zabner J, Couture L, Gregory R, Graham S, Smith A, Welsh M. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993 ; 75 : 207-16.
27. Boucher RC, Knowles MR, Johnson LG, Olsen JC, Pickles R, Wilson JM, Engelhardt J, Yang Y, Grossman M. Gene therapy for cystic fibrosis using El-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Hum Gene Ther 1994 ; 5 : 615-39.
28. Kohn D, Weinberg KI, Parkman P, Lenarsky C, Crooks GM, Shaw K, Hanley ME, Lawrence K, Anett G, Brooks JS, Wara D, Elder M, Bowen T, Hershfield MS, Berenson RI, Moen RC, Mullen CA, Blaese RM. Gene therapy for neonates with ADA-deficient SCID by retroviral-mediated transfer of the human ADA cDNA into umbilical cord CD34: cells. Blood 1993 ; 82 (suppl 1) : 315a (abstr 1245).
29. Grossman M, Raper S, Kozarsky K, Stein E, Engelhardt J, Muller D, Lupien P, Wilson J. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nature Genet 1994 ; 6 : 335-41.
30. Viagene Inc, Haubrich R, McCutchan JA. An open-label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1 IIIB env/rev retroviral vector) in HIV-1-infected subjects. Hum Gene Ther 1995 ; 6 : 941-55.
31. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Gene Shearer, Chang L, Chiang W, Tolstshey P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. T Lymphocytes-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995 ; 270 : 475-80.